WIRK, Baldeep; LIM, Jin. Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma. Journal of Hematology, [S. l.], v. 14, n. 3, p. 146–151, 2025. DOI: 10.14740/jh2046. Disponível em: https://jh.elmerpub.com/jh/article/view/2046.. Acesso em: 17 jun. 2025.